Dynamical Analysis of Tumor‐Virus‐Immune System With Two Delays
Mathematical Methods in the Applied Sciences · 2026-12 · 49 (18) · 18249-18275
DOI: 10.1002/mma.70989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mathematical Methods in the Applied Sciences, online erschienen am 20.09.2026. Verfasst von Renxiang Shi und 2 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Jiangsu Commission of Health, Nanjing University of Chinese Medicine, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
For the importance of oncolytic virotherapy against tumor, we propose a tumor‐virus‐immune system with oncolytic virotherapy and two delays, where one delay denotes the time period of viral lytic cycle within infected tumor cells, the other delay denotes activation duration of CTLs (Cytotoxic T Lymphocytes) by oncolytic virus. First, we discuss the existence of equilibrium points, the positivity and boundedness of solutions of the system. Then, in absence of delays, we study Hopf bifurcation caused by infection rate of virus for tumor cells. In presence of delays, we study Hopf bifurcation caused by two delays. At last, simulations are given to support our results.
Förderung
- Jiangsu Commission of Health
- Nanjing University of Chinese Medicine
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Shi, R., Hu, Z., & Zhang, H. (2026). Dynamical Analysis of Tumor‐Virus‐Immune System With Two Delays. Mathematical Methods in the Applied Sciences, 49(18), 18249-18275. https://doi.org/10.1002/mma.70989
Vancouver
Shi R, Hu Z, Zhang H. Dynamical Analysis of Tumor‐Virus‐Immune System With Two Delays. Mathematical Methods in the Applied Sciences. 2026;49(18):18249-18275. doi:10.1002/mma.70989
BibTeX
@article{Shi2026,
author = {Shi, Renxiang and Hu, Zonghai and Zhang, Han‐Su},
title = {Dynamical Analysis of Tumor‐Virus‐Immune System With Two Delays},
journal = {Mathematical Methods in the Applied Sciences},
year = {2026},
volume = {49},
number = {18},
pages = {18249--18275},
doi = {10.1002/mma.70989}
}
EUVIMED